GlassScriptPhysician profile
Ashima K Gupta
NPI 1073509592
$4,932.77
in general payments reported to CMS, 2019-2025
28 companies · $1,186 in 2025
The $1,186 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $281 · 2021: $545 · 2022: $994 · 2023: $505 · 2024: $428 · 2025: $1,186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,118.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $962.48 | 2019-2024 | Eylea Hd, Eylea |
| Amgen INC. | $408.60 | 2025 | Tepezza, Uplizna |
| Tarsus Pharmaceuticals, INC. | $395.46 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $255.00 | 2019 | |
| Horizon Therapeutics Plc | $246.26 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $223.40 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $207.40 | 2022-2024 | Scoutpro Osmolarity System |
| Allergan, INC. | $187.58 | 2019-2020 | |
| Alcon Vision LLC | $180.90 | 2023-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Penumbra, INC. | $177.00 | 2021 | |
| Gt Medical Technologies, INC | $171.96 | 2025 | Gammatile |
| Abiomed | $145.77 | 2025 | |
| Sight Sciences, INC. | $143.24 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2024 | |
| Genentech USA, INC. | $121.86 | 2023 | Vabysmo |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $119.70 | 2019 | |
| Merck Sharp & Dohme LLC | $114.83 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.97 | 2019-2020 | |
| Abbvie INC. | $112.39 | 2022 | |
| Ocular Therapeutix, INC. | $110.82 | 2022 | |
| Sun Pharmaceutical Industries INC. | $107.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $88.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $86.40 | 2020 | |
| Apellis Pharmaceuticals, INC. | $39.68 | 2022-2023 | Syfovre |
| Harrow Eye, LLC | $34.66 | 2024-2025 | Triesence, Iheezo |
| Dompe US, INC. | $19.31 | 2022 | |
| Oyster Point Pharma, INC. | $16.88 | 2022 | |
| Rxsight INC | $16.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashima Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.